Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy.
about
Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytesChromatin states modify network motifs contributing to cell-specific functions.Selective inhibitors of nuclear export (SINE)--a novel class of anti-cancer agents.Patterns of DNMT1 Promoter Methylation in Patients with Acute Lymphoblastic Leukemia.
P2860
Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genetic methylation and lympho ...... gression and targeted therapy.
@ast
Genetic methylation and lympho ...... gression and targeted therapy.
@en
type
label
Genetic methylation and lympho ...... gression and targeted therapy.
@ast
Genetic methylation and lympho ...... gression and targeted therapy.
@en
prefLabel
Genetic methylation and lympho ...... gression and targeted therapy.
@ast
Genetic methylation and lympho ...... gression and targeted therapy.
@en
P2093
P2860
P356
P1433
P1476
Genetic methylation and lympho ...... gression and targeted therapy.
@en
P2093
P2860
P2888
P356
10.1186/2050-7771-1-24
P577
2013-08-14T00:00:00Z
P5875
P6179
1008540301